Mark Esser, PhD, was appointed the inaugural chief scientific officer and head of the upcoming Paul and Diane Manning Institute of Biotechnology at Charlottesville-based University of Virginia. In his ...

Mark Esser, an executive at Big Pharma firm AstraZeneca, has been named the inaugural leader of UVa's future Manning ...

Mark T. Esser, a vice president for the research-based biopharmaceutical company AstraZeneca, earned a doctorate in microbiology from the UVA School of Medicine in 1998. His appointment to the Manning ...

The University of Virginia has named Mark T. Esser, PhD, a premier expert in the development of new medical treatments and tests, to lead the upcoming Paul and Diane Manning Institute of ...

Mark T. Esser, vice president for vaccines and immune therapies at pharmaceutical giant AstraZeneca, will be the inaugural chief scientific officer and leader of the Paul and Diane Manning Institute ...

Mark T. Esser, vice president for vaccines and immune therapies at pharmaceutical giant AstraZeneca, will be the inaugural chief scientific officer and leader of the Paul and Diane Manning Institute ...

Mark T. Esser, PhD, a premier expert in the development of new medical treatments and tests, has been tapped to lead the University of Virginia's upcoming Paul and Diane Manning Institute of ...